✦ LIBER ✦

Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer

✍ Scribed by Destin Black; Douglas A. Levine; Linda Nicoll; Joanne F. Chou; Alexia Iasonos; Carol L. Brown; Yukio Sonoda; Dennis S. Chi; Mario M. Leitao; Nadeem R. Abu-Rustum; Sarah E. Ferguson; Richard R. Barakat

Book ID: 113961465
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 122 KB
Volume: 109
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2007.12.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant intraperitoneal chemotherapy

Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study

✍ Francisco C. Muñoz-Casares; Sebastián Rufián; Álvaro Arjona-Sánchez; María J. Ru 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 253 KB

Prophylaxis with low molecular weight he

Prophylaxis with low molecular weight heparin reduces the risk for catheter-related venous thrombosis in cancer patients with centrally but not peripherally inserted central venous catheters for administration of chemotherapy

✍ Tesselaar, M.; Ouwerkerk, J.; Rosendaal, F.R.; Osanto, S. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Risk factors for upper limb deep vein th

Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients

✍ Melina Verso; Giancarlo Agnelli; Pieter W. Kamphuisen; Walter Ageno; Mario Bazza 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 158 KB

Analysis of postoperative complications

Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers

✍ Lauren S. Krill; Stefanie M. Ueda; Melissa Gerardi; Robert E. Bristow 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Results of an Open-Label Study to Evalua

Results of an Open-Label Study to Evaluate the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated with Carboplatin-Containing Chemotherapy in Patients with Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Carcinoma (Stage I-IV) or Papillary Serous Cancer of the Uterus

✍ Patrick Timmins III; Daniel Kredentser; Kenneth Hancock; Mark Messing; Kristi A. 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 104 KB